Schwartz PE - Search Results

1

Malignant transformation of myomas: myth or reality?

Schwartz PE, Kelly MG. Schwartz PE, et al. Obstet Gynecol Clin North Am. 2006 Mar;33(1):183-98, xii. doi: 10.1016/j.ogc.2005.12.003. Obstet Gynecol Clin North Am. 2006. PMID: 16504815

2

Unsuspected leiomyosarcoma: treatment with a gonadotropin-releasing hormone analogue.

Meyer WR, Mayer AR, Diamond MP, Carcangiu ML, Schwartz PE, DeCherney AH. Meyer WR, et al. Among authors: schwartz pe. Obstet Gynecol. 1990 Mar;75(3 Pt 2):529-32. Obstet Gynecol. 1990. PMID: 2106109

3

Malignant mixed müllerian tumor of the uterus arising in association with a viable gestation.

Scioscia AL, Merino MJ, Haas M, Copel JA, Schwartz PE. Scioscia AL, et al. Among authors: schwartz pe. Obstet Gynecol. 1988 Jun;71(6 Pt 2):1047-50. Obstet Gynecol. 1988. PMID: 2836770

4

Leiomyosarcomas: clinical presentation.

Schwartz LB, Diamond MP, Schwartz PE. Schwartz LB, et al. Among authors: schwartz pe. Am J Obstet Gynecol. 1993 Jan;168(1 Pt 1):180-3. doi: 10.1016/s0002-9378(12)90910-2. Am J Obstet Gynecol. 1993. PMID: 8420323 Review.

5

Minimal uterine serous carcinoma: a clinicopathological study of 40 cases.

Hui P, Kelly M, O'Malley DM, Tavassoli F, Schwartz PE. Hui P, et al. Among authors: schwartz pe. Mod Pathol. 2005 Jan;18(1):75-82. doi: 10.1038/modpathol.3800271. Mod Pathol. 2005. PMID: 15389257 Free article.

6

Patients with uterine papillary serous cancers may benefit from adjuvant platinum-based chemoradiation.

Kelly MG, O'Malley D, Hui P, McAlpine J, Dziura J, Rutherford TJ, Azodi M, Chambers SK, Schwartz PE. Kelly MG, et al. Among authors: schwartz pe. Gynecol Oncol. 2004 Dec;95(3):469-73. doi: 10.1016/j.ygyno.2004.08.030. Gynecol Oncol. 2004. PMID: 15581948

7

Weekly topotecan in heavily pretreated patients with recurrent epithelial ovarian carcinoma.

O'Malley DM, Azodi M, Makkenchery A, Tangir J, McAlpine J, Kelly M, Schwartz P, Rutherford T. O'Malley DM, et al. Gynecol Oncol. 2005 Aug;98(2):242-8. doi: 10.1016/j.ygyno.2005.04.032. Gynecol Oncol. 2005. PMID: 15992916

8

Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy.

Kelly MG, O'malley DM, Hui P, McAlpine J, Yu H, Rutherford TJ, Azodi M, Schwartz PE. Kelly MG, et al. Among authors: schwartz pe. Gynecol Oncol. 2005 Sep;98(3):353-9. doi: 10.1016/j.ygyno.2005.06.012. Gynecol Oncol. 2005. PMID: 16005947

9

Atypical presentations of carboplatin hypersensitivity reactions: characterization and management in patients with gynecologic malignancies.

McAlpine JN, Kelly MG, O'malley DM, Azodi M, Coombe K, Schwartz PE, Rutherford TJ. McAlpine JN, et al. Among authors: schwartz pe. Gynecol Oncol. 2006 Oct;103(1):288-92. doi: 10.1016/j.ygyno.2006.03.007. Epub 2006 May 2. Gynecol Oncol. 2006. PMID: 16647749

10

Neoadjuvant chemotherapy lessens surgical morbidity in advanced ovarian cancer and leads to improved survival in stage IV disease.

Hou JY, Kelly MG, Yu H, McAlpine JN, Azodi M, Rutherford TJ, Schwartz PE. Hou JY, et al. Among authors: schwartz pe. Gynecol Oncol. 2007 Apr;105(1):211-7. doi: 10.1016/j.ygyno.2006.11.025. Epub 2007 Jan 18. Gynecol Oncol. 2007. PMID: 17239941

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

438 results

Search Page

Filters